Mydecine Innovations Group Inc (OTCMKTS:MYCO) looks forward to starting its Phase 2A PTSD clinical trials and sees ethica CRO (“ethica CRO”) as an ideal partner. After considering its excellent work towards introducing a new ethical dimension to clinical research, the business giant has chosen the partner.
The other thing that makes the partner ideal is that it became the first CRO to receive accreditation as a significant player in a human research protection program conducted back in 2006. Some people would also see the CRO getting accreditation from about three accrediting bodies as a significant achievement and qualification for the new partnership.
The CEO of Mydecine Innovations Group, Josh Bartch, applauded the move to collaborate with such a top-class partner. He hopes that the CRO’s outstanding expertise in managing clinical studies will be a great addition to their success in the upcoming Phase 2A PTSD clinical trials.
The official sees the move to bring onboard the new partner to show their outstanding preparations towards discovering how the brain reacts to psychedelics. The parties will also be looking to establish what a psychedelic experience could cause in biological underpinnings.
Mydecine wants to push its clinical development to the pinnacle, and it will be counting on its partner’s unparalleled experience in wide-ranging trials. Ethica CRO is known for its deep clinical expertise and will help a lot with the trial preparations.
The Managing Director of ethica CRO Murray Jensen is happy about the impressive mental health treatment changes. He terms Psychedelics and psychedelic-assisted therapies as some of the game-changers as they continue to progress with their innovation drive.
Mydecine is pleased to announce its partnership with Microdose Psychedelic Insights, a move that will see the two focus on unveiling a free, live webinar series. Reports show that the series will entirely focus on the Renaissance of Psychedelics.
Global Hemp Group Inc (OTCMKTS:GBHPF) Inks A Pact To Takeover Western Sierra Resource Corp (OTCMKTS:WSRC): Becomes A Member Of USHBA
Post Views: 50 Global Hemp Group Inc (OTCMKTS:GBHPF) signed a deal with Prescient Strategies Group LLC to take over all...
Global Cannabis Applications Corp (OTCMKTS:FUAPF) Enters A Pact With CBD Agrocasa To Apply Efixii QR Codes On CBD Oil Tinctures
Post Views: 51 Global Cannabis Applications Corp (OTCMKTS:FUAPF) signs an MOU (Memorandum of Understanding) with CBD Agrocasa. As per the...
Heritage Cannabis Holdings Corp (OTCMKTS:HERTF) Ships Derivative Products Under RAD Brand To AGLC And BCLDB For Sale In The Provinces Through Authorized Channels
Post Views: 52 Heritage Cannabis Holdings Corp (OTCMKTS:HERTF) commenced shipping RAD Vapes, RAD Crumble, feelgood topical, RAD CBD Isolate, and...
Tilray Inc (NASDAQ:TLRY) Posts Revenues Of $56.6 Million In Q4 2020: Lowers Annualized Costs By $57 Million YoY
Post Views: 176 Tilray Inc (NASDAQ:TLRY) posts solid growth by strengthening its business in 2020 despite the COVID-19 pandemic. The...
Nutritional High International Inc (OTCMKTS:SPLIF) Posts Drop Of 47.88% In Revenues In 2020
Post Views: 183 Nutritional High International Inc (OTCMKTS:SPLIF) realized cost savings by restructuring its obligations and eliminating unprofitable operations. These...
OrganiGram Holdings Inc (NASDAQ:OGI) Reports A Drop Of 11% In Revenues In Q1 2021: Appoints Marni Wieshofer To The Board Of Directors
Post Views: 161 OrganiGram Holdings Inc (NASDAQ:OGI) posted a decline of 11% in revenues to $25.28 million in Q1 2021....